- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/00 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patent holdings for IPC class C07D 215/00
Total number of patents in this class: 268
10-year publication summary
|
13
|
18
|
4
|
18
|
7
|
9
|
8
|
3
|
4
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Janssen Pharmaceutica N.V. | 3383 |
9 |
| Boehringer Ingelheim International GmbH | 4648 |
8 |
| Vertex Pharmaceuticals Incorporated | 1595 |
7 |
| Merck Sharp & Dohme LLC | 3741 |
7 |
| Life Technologies Corporation | 3299 |
6 |
| Novartis AG | 10850 |
5 |
| Bristol-myers Squibb Company | 4893 |
5 |
| Allergan, Inc. | 2346 |
5 |
| OPKO Health, Inc. | 45 |
5 |
| Theravance Biopharma R&D IP, LLC | 458 |
5 |
| Amgen Inc. | 4044 |
4 |
| Exelixis, Inc. | 398 |
4 |
| Merck Sharp & Dohme Corp. | 2190 |
3 |
| Vertex Pharmaceuticals (europe) Limited | 17 |
3 |
| Alcon, Inc. | 5439 |
3 |
| Alkermes Pharma Ireland Limited | 270 |
3 |
| Almirall, S.A. | 491 |
3 |
| Children's Medical Center Corporation | 1864 |
3 |
| Hoffmann-La Roche Inc. | 3422 |
2 |
| Syngenta Participations AG | 1902 |
2 |
| Other owners | 176 |